Rezolute (RZLT) Assets Average (2011 - 2026)
Rezolute (RZLT) posted Assets Average of $132.0 million for Q1 2026, down 11.17% sequentially from $148.6 million in Q4 2025, and up 27.74% YoY from $103.4 million in Q1 2025.
Rezolute (RZLT) Assets Average (2011 - 2026) Analysis & Trends
Rezolute has reported Assets Average for 16 years, with the latest figure at $132.0 million in Q1 2026.
- Quarterly Assets Average rose 27.74% year-over-year to $132.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $132.0 million (up 27.74% YoY) and the FY2025 annual result came in at $154.1 million, up 20.19% from the prior year.
- Assets Average eased to $132.0 million in Q1 2026 per RZLT's latest filing, from $148.6 million in the prior quarter.
- Over five years, Assets Average peaked at $167.1 million in Q3 2025 and troughed at $76.5 million in Q1 2022.
- A 5-year average of $125.2 million and a median of $128.1 million in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2022 and 2024: Assets Average jumped 279.02% in 2022, then sank 33.24% in 2024.
- Over 5 years, Assets Average stood at $153.1 million in 2022, then fell by 29.73% to $107.6 million in 2023, then rose by 9.42% to $117.7 million in 2024, then advanced by 26.28% to $148.6 million in 2025, then retreated by 11.17% to $132.0 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $132.0 million, $148.6 million, and $167.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Rezolute | 442.94 Mn | 442.94 Mn | - | 132.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 132.04 Mn |
| Dec 31, 2025 | 148.65 Mn |
| Sep 30, 2025 | 167.08 Mn |
| Jun 30, 2025 | 135.11 Mn |
| Mar 31, 2025 | 103.37 Mn |
| Dec 31, 2024 | 117.71 Mn |
| Sep 30, 2024 | 128.08 Mn |
| Jun 30, 2024 | 110.24 Mn |
| Mar 31, 2024 | 94.94 Mn |
| Dec 31, 2023 | 107.57 Mn |
| Sep 30, 2023 | 118.36 Mn |
| Jun 30, 2023 | 128.96 Mn |
| Mar 31, 2023 | 142.21 Mn |
| Dec 31, 2022 | 153.10 Mn |
| Sep 30, 2022 | 154.20 Mn |
| Jun 30, 2022 | 111.00 Mn |
| Mar 31, 2022 | 76.49 Mn |
| Dec 31, 2021 | 61.08 Mn |
| Sep 30, 2021 | 40.68 Mn |
| Jun 30, 2021 | 37.77 Mn |